clinical trial · NCT06132919
Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)
Vulvar Lichen SclerosusMC2-25 creamMC2-25 vehicle
brief summary
The purpose of this study is to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women with vulvar lichen schelosus (VLS).
started
Oct 11, 2023
primary completion
Nov 8, 2024
completion
Nov 8, 2024
last updated
Oct 15, 2025
detailed description
In this study, subjects who fulfil all inclusion and exclusion criteria are enrolled.
Eligible subjects will be randomized in a 1:1 ratio to MC2-25 cream or MC2-25 vehicle, respectively.
The subjects will apply the assigned investigational medicinal product (IMP) daily for 12 weeks.
official title
A Parallel Group (2-arm), Randomised, Double-blind, 12-week Trial to Explore the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Women Diagnosed With Vulvar Lichen Sclerosus (VLS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol